View in EDS HTML Full Text PDF Full Text

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC.

Saved in:
Bibliographic Details
Title: HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC.
Authors: Mei, Jie1 (AUTHOR), Jiang, Guanyu2 (AUTHOR), Chen, Yundi3 (AUTHOR), Xu, Yongrui2 (AUTHOR), Wan, Yuan3 (AUTHOR), Chen, Ruo2 (AUTHOR), Liu, Feng2 (AUTHOR), Mao, Wenjun2 (AUTHOR) maowenjun1@njmu.edu.cn, Zheng, Mingfeng2 (AUTHOR) zhengmfmedical@126.com, Xu, Junying1 (AUTHOR) doctorxyj123@163.com
Source: BMC Cancer. 7/6/2022, Vol. 22 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 157835365
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mei%2C+Jie%22">Mei, Jie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Guanyu%22">Jiang, Guanyu</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Yundi%22">Chen, Yundi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Yongrui%22">Xu, Yongrui</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Yuan%22">Wan, Yuan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Ruo%22">Chen, Ruo</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Feng%22">Liu, Feng</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mao%2C+Wenjun%22">Mao, Wenjun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> maowenjun1@njmu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Zheng%2C+Mingfeng%22">Zheng, Mingfeng</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> zhengmfmedical@126.com</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Junying%22">Xu, Junying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> doctorxyj123@163.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 7/6/2022, Vol. 22 Issue 1, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=157835365
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-022-09840-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mei, Jie
      – PersonEntity:
          Name:
            NameFull: Jiang, Guanyu
      – PersonEntity:
          Name:
            NameFull: Chen, Yundi
      – PersonEntity:
          Name:
            NameFull: Xu, Yongrui
      – PersonEntity:
          Name:
            NameFull: Wan, Yuan
      – PersonEntity:
          Name:
            NameFull: Chen, Ruo
      – PersonEntity:
          Name:
            NameFull: Liu, Feng
      – PersonEntity:
          Name:
            NameFull: Mao, Wenjun
      – PersonEntity:
          Name:
            NameFull: Zheng, Mingfeng
      – PersonEntity:
          Name:
            NameFull: Xu, Junying
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 07
              Text: 7/6/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 14712407
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Cancer
              Type: main
ResultId 1